The Family of S100 Cell Signaling Proteins

Handbook of Cell Signaling, Second Edition

Volumn 2, Issue , 2009, Pages 983-993

  Heizmann, Claus W ^a   Fritz, Günter ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956855236     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374145-5.00124-8     Document Type: Chapter

References (54)

1. BW Schafer, R Wicki, D Engelkamp, MG Mattei and CW Heizmann (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25 638-643.
2. I Marenholz, CW Heizmann and G Fritz (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322 1111-1122.
3. I Marenholz, RC Lovering and CW Heizmann (2006) An update of the S100 nomenclature. Biochim Biophys Acta 1763 1282-1283.
4. I Marenholz and CW Heizmann (2004) S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors. Biochem Biophys Res Commun 313 237-244.
5. GE Davey, P Murmann and CW Heizmann (2001) Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J Biol Chem 276 30,819-30,826.
6. A Rammes, J Roth, M Goebeler, M Klempt, M Hartmann and C Sorg (1997) Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272 9496-9502.
7. RA Newton and N Hogg (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160 1427-1435.
8. HJ Huttunen, J Kuja-Panula, G Sorci, AL Agneletti, R Donato and H Rauvala (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275 40,096-40,105.
9. N Ambartsumian, J Klingelhofer, M Grigorian, C Christensen, M Kriajevska, E Tulchinsky, G Georgiev, V Berezin, E Bock, J Rygaard, R Cao, Y Cao and E Lukanidin (2001) The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20 4685-4695.
10. MA Hofmann, S Drury, C Fu, W Qu, A Taguchi, Y Lu, C Avila, N Kambham, A Bierhaus, P Nawroth, MF Neurath, T Slattery, D Beach, J McClary, M Nagashima, J Morser, D Stern and AM Schmidt (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 889-901.
11. D Kiryushko, V Novitskaya, V Soroka, J Klingelhofer, E Lukanidin, V Berezin and E Bock (2006) Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26 3625-3638.
12. IP Korndorfer, F Brueckner and A Skerra (2007) The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J Mol Biol 370 887-898.
13. N Leukert, T Vogl, K Strupat, R Reichelt, C Sorg and J Roth (2006) Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol 359 961-972.
14. OV Moroz, AA Antson, EJ Dodson, HJ Burrell, SJ Grist, RM Lloyd, NJ Maitland, GG Dodson, KS Wilson, E Lukanidin and IB Bronstein (2002) The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr D Biol Crystallogr 58 407-413.
15. T Ostendorp, E Leclerc, A Galichet, M Koch, N Demling, B Weigle, CW Heizmann, PM Kroneck and G Fritz (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J 26 3868-3878.
16. M Koch, S Bhattacharya, T Kehl, M Gimona, M Vasak, W Chazin, CW Heizmann, PM Kroneck and G Fritz (2007) Implications on zinc binding to S100A2. Biochim Biophys Acta 1773 457-470.
17. G Fritz, CW Heizmann and PM Kroneck (1998) Probing the structure of the human Ca2+- and Zn2+-binding protein S100A3: spectroscopic investigations of its transition metal ion complexes, and three-dimensional structural model. Biochim Biophys Acta 1448 264-276.
18. DE Brodersen, J Nyborg and M Kjeldgaard (1999) Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 38 1695-1704.
19. OV Moroz, AA Antson, SJ Grist, NJ Maitland, GG Dodson, KS Wilson, E Lukanidin and IB Bronstein (2003) Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr D Biol Crystallogr 59 859-867.
20. GE Ackermann, AA Domenighetti, A Deten, I Bonath, I Marenholz, T Pedrazzini, P Erne and CW Heizmann (2008) S100A1 deficieny results in prolonged ventricular repolarization in response to sympathetic activation. Gen Physiol Biophys 27 127-142.
21. Gusev K, Ackermann GE, Heizmann CW, Niggli E. Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein. Gen Physiol Biophys 2009.
22. ST Pleger, A Remppis, B Heidt, M Volkers, JK Chuprun, M Kuhn, RH Zhou, E Gao, G Szabo, D Weichenhan, OJ Muller, AD Eckhart, HA Katus, WJ Koch and P Most (2005) S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12 1120-1129.
23. N Ambartsumian, M Grigorian and E Lukanidin (2005) Genetically modified mouse models to study the role of metastasis-promoting S100A4(mts1) protein in metastatic mammary cancer. J Dairy Res 72 27-33. Spec. No
24. C El-Naaman, B Grum-Schwensen, A Mansouri, M Grigorian, E Santoni-Rugiu, T Hansen, M Kriajevska, BW Schafer, CW Heizmann, E Lukanidin and N Ambartsumian (2004) Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 23 3670-3680.
25. G Wang, S Zhang, DG Fernig, M Martin-Fernandez, PS Rudland and R Barraclough (2005) Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24 1445-1454.
26. DM Helfman, EJ Kim, E Lukanidin and M Grigorian (2005) The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92 1955-1958.
27. U Stein, F Arlt, W Walther, J Smith, T Waldman, ED Harris, SD Mertins, CW Heizmann, D Allard, W Birchmeier, PM Schlag and RH Shoemaker (2006) The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131 1486-1500.
28. J Roth, T Vogl, C Sorg and C Sunderkotter (2003) Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 24 155-158.
29. MM McCormick, F Rahimi, YV Bobryshev, K Gaus, H Zreiqat, H Cai, RS Lord and CL Geczy (2005) S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280 41,521-41,529.
30. JA Hobbs, R May, K Tanousis, E McNeill, M Mathies, C Gebhardt, R Henderson, MJ Robinson and N Hogg (2003) Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 23 2564-2576.
31. MP Manitz, B Horst, S Seeliger, A Strey, BV Skryabin, M Gunzer, W Frings, F Schonlau, J Roth, C Sorg and W Nacken (2003) Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 23 1034-1043.
32. T Vogl, K Tenbrock, S Ludwig, N Leukert, C Ehrhardt, MA van Zoelen, W Nacken, D Foell, T van der Poll, C Sorg and J Roth (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13 1042-1049.
33. RJ Passey, E Williams, AM Lichanska, C Wells, S Hu, CL Geczy, MH Little and DA Hume (1999) A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J Immunol 163 2209-2216.
34. E Donier, F Rugiero, K Okuse and JN Wood (2005) Annexin II light chain p11 promotes functional expression of acid-sensing ion channel ASIC1a. J Biol Chem 280 38,666-38,672.
35. SF van de Graaf, JG Hoenderop, D Gkika, D Lamers, J Prenen, U Rescher, V Gerke, O Staub, B Nilius and RJ Bindels (2003) Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J 22 1478-1487.
36. P Svenningsson, K Chergui, I Rachleff, M Flajolet, X Zhang, M El Yacoubi, JM Vaugeois, GG Nomikos and P Greengard (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311 77-80.
37. T Sharp (2006) Neuroscience. A new molecule to brighten the mood. Science 311 45-46.
38. E Sturchler, JA Cox, I Durussel, M Weibel and CW Heizmann (2006) S100A16, a novel calcium-binding protein of the EF-hand superfamily. J Biol Chem 281 38,905-38,917.
39. M Hollstein, D Sidransky, B Vogelstein and CC Harris (1991) p53 mutations in human cancers. Science 253 49-53.
40. K Hibi, S Fujitake, T Takase, Y Kodera, K Ito, S Akiyama, M Shirane and A Nakao (2003) Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway. Clin Cancer Res 9 4282-4285.
41. UM Moll, M LaQuaglia, J Benard and G Riou (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92 4407-4411.
42. JS Andersen, YW Lam, AK Leung, SE Ong, CE Lyon, AI Lamond and M Mann (2005) Nucleolar proteome dynamics. Nature 433 77-83.
43. MA Reddy, SL Li, S Sahar, YS Kim, ZG Xu, L Lanting and R Natarajan (2006) Key role of SRC kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281 13,685-13,693.
44. E Leclerc, G Fritz, M Weibel, CW Heizmann and A Galichet (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (Receptor for Advanced Glycation End products) immunoglobulin domains. J Biol Chem 282 31,317-31,331.
45. A Bierhaus, PM Humpert, M Morcos, T Wendt, T Chavakis, B Arnold, DM Stern and PP Nawroth (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83 876-886.
46. SF Yan, GR Barile, V D’Agati, S Du Yan, R Ramasamy and AM Schmidt (2007) The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr Diab Rep 7 146-153.
47. Q Ding and JN Keller (2005) Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci Letts 373 67-72.
48. A Bierhaus, KM Haslbeck, PM Humpert, B Liliensiek, T Dehmer, M Morcos, AA Sayed, M Andrassy, S Schiekofer, JG Schneider, JB Schulz, D Heuss, B Neundorfer, S Dierl, J Huber, H Tritschler, AM Schmidt, M Schwaninger, HU Haering, E Schleicher, M Kasper, DM Stern, B Arnold and PP Nawroth (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114 1741-1751.
49. AM Schmidt, SD Yan, SF Yan and DM Stern (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108 949-955.
50. R Deane, S Du Yan, RK Submamaryan, B LaRue, S Jovanovic, E Hogg, D Welch, L Manness, C Lin, J Yu, H Zhu, J Ghiso, B Frangione, A Stern, AM Schmidt, DL Armstrong, B Arnold, B Liliensiek, P Nawroth, F Hofman, M Kindy, D Stern and B Zlokovic (2003) RAGE mediates amyloid-beta peptide transport across the blood–brain barrier and accumulation in brain. Nat Med 9 907-913.
51. LF Lue, DG Walker, L Brachova, TG Beach, J Rogers, AM Schmidt, DM Stern and SD Yan (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer’s disease: identification of a cellular activation mechanism. Exp Neurol 171 29-45.
52. MT Goova, J Li, T Kislinger, W Qu, Y Lu, LG Bucciarelli, S Nowygrod, BM Wolf, X Caliste, SF Yan, DM Stern and AM Schmidt (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159 513-525.
53. A Taguchi, DC Blood, G del Toro, A Canet, DC Lee, W Qu, N Tanji, Y Lu, E Lalla, C Fu, MA Hofmann, T Kislinger, M Ingram, A Lu, H Tanaka, O Hori, S Ogawa, DM Stern and AM Schmidt (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405 354-360.
54. CW Heizmann, GA Ackermann and A Galichet (2007) Pathologies involving the S100 proteins and RAGE. Subcell Biochem 45 93-138.